Cargando…

Biosimilars in oncology

Detalles Bibliográficos
Autor principal:	Tabernero, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Podcast
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215690/ https://www.ncbi.nlm.nih.gov/pubmed/30430024 http://dx.doi.org/10.1136/esmoopen-2018-000456

Ejemplares similares

New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology
por: Senkus, Elżbieta
Publicado: (2017)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Recent advances in adjuvant therapy for patients with melanoma
por: Weber, Jeffrey
Publicado: (2018)

Immunotherapy in lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

New therapeutic targets in the inflammatory microenvironment
por: Tartour, Eric
Publicado: (2018)

ESMO Leaders Generation Programme: an alumni insight
por: Arruda, Leticia De Mattos, et al.
Publicado: (2018)

Questions asked in the everyday practice: immune checkpoint inhibitors
por: Haanen, John B A G
Publicado: (2018)

Macrophage repolarisation therapy in colorectal cancer
por: Halama, Niels
Publicado: (2018)

Epigenetic biomarkers in cancer
por: Egger, Gerda
Publicado: (2018)

Initial experience with the bispecific anti-CEA anti-CD3 antibody and its expected impact on future treatment for patients with colorectal cancer
por: Argiles, Guillem
Publicado: (2018)

Report from the ESMO 2018 presidential symposium—Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE
por: Parker, Chris
Publicado: (2018)

Introducing the Metastatic Breast Cancer Project: a novel patient-partnered initiative to accelerate understanding of MBC
por: Parry, Marina
Publicado: (2018)

Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

Tumor evolution in non-small-cell lung cancer
por: Parry, Marina
Publicado: (2018)

ESMO 2018 presidential symposium—IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer
por: Schmid, Peter
Publicado: (2018)

Highlights in breast cancer from ASCO 2016
por: Cardoso, Fatima
Publicado: (2016)

Tumour network in glioma
por: Winkler, Frank
Publicado: (2016)

Highlights from the San Antonio Breast Cancer Symposium 2015
por: Jassem, Jacek
Publicado: (2016)

ASCO highlights podcast: head and neck cancers
por: Merlano, Marco
Publicado: (2016)

Cancer genome: highlights of a Nature Medicine perspective
por: Voest, Emile
Publicado: (2016)

ASCO: practice changing studies in gastrointestinal cancer
por: Prager, Gerald
Publicado: (2017)

How to Conduct a Clinical Trial During a Pandemic—An Interview with Dr. David Boulware
Publicado: (2020)

Debating the Top ID Internet Resources with Dr. Monica Mahoney
Publicado: (2020)

An ID Doctor’s Confrontation with His Own Case of COVID-19 – An Interview with Dr. Michael Saag
Publicado: (2020)

Adjuvant and neoadjuvant therapies in melanoma
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

A good meme is worth a thousand words
Publicado: (2020)

Tracking COVID-19 from a Journalist's Perspective with STAT's Helen Branswell
Publicado: (2020)

COVID-19’s Siege on Elmhurst Hospital in New York City – An interview with Dr. Eric Bressman
Publicado: (2020)

ESMO Open special series on new emerging targets in cancer immunotherapy
por: Lambertini, Matteo
Publicado: (2020)

ESMO Open: news in breast cancer 2019
por: Lambertini, Matteo
Publicado: (2020)

ESMO presidential symposium wrap up: the ClarIDHy trial
por: Abou-Alfa, Ghassan K
Publicado: (2020)

News on the horizon in glioblastoma therapy
por: Herrlinger, Ulrich
Publicado: (2020)

Highlights in lung cancer in 2019
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

ESMO-Magnitude of Clinical Benefit Scale (MCBS) group
por: Amaral, Teresa
Publicado: (2019)

What is new on the horizon in melanoma brain metastasis?
por: Margolin, Kim
Publicado: (2019)

ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib
por: Lambertini, M., et al.
Publicado: (2020)

ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer
por: Matikas, A., et al.
Publicado: (2020)

ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer
por: Punie, K., et al.
Publicado: (2020)

Calling for an Evidence-Based Approach to COVID-19 – An interview with Dr. Vinay Prasad
Publicado: (2020)

Debating the top animal-related infections – An interview with Dr. Jeanne Marrazzo
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67lldrl3d8a1v4tas9euksr2e9